Therapeutic Potential of Neu1 in Alzheimer’s Disease Via the Immune System
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in American Journal of Alzheimer's Disease and Other Dementias®
- Vol. 36
Abstract
Alzheimer’s Disease (AD) is pathologically characterized by the accumulation of soluble oligomers causing extracellular beta-amyloid deposits in form of neuritic plaques and tau-containing intraneuronal neurofibrillary tangles in brain. One proposed mechanism explaining the formation of these proteins is impaired phagocytosis by microglia/macrophages resulting in defective clearance of soluble oligomers of beta-amyloid stimulating aggregation of amyloid plaques subsequently causing AD. However, research indicates that activating macrophages in M2 state may reduce toxic oligomers. NEU1 mutation is associated with a rare disease, sialidosis. NEU1 deficiency may also cause AD-like amyloidogenic process. Amyloid plaques have successfully been reduced using NEU1.Thus, NEU1 is suggested to have therapeutic potential for AD, with lysosomal exocytosis being suggested as underlying mechanism. Studies however demonstrate that NEU1 may activate macrophages in M2 state, which as noted earlier, is crucial to reducing toxic oligomers. In this review, authors discuss the potential therapeutic role of NEU1 in AD via immune system.Keywords
This publication has 79 references indexed in Scilit:
- Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like PathologyPLOS ONE, 2013
- Amyloid-β oligomers link depressive-like behavior and cognitive deficits in miceMolecular Psychiatry, 2012
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- In vitro Pb exposure disturbs the balance between Aβ production and elimination: The role of AβPP and neprilysinNeuroToxicology, 2011
- Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage diseaseBiochemical Society Transactions, 2010
- Regulation of Phagocytosis in Macrophages by Neuraminidase 1Journal of Biological Chemistry, 2010
- Involvement of Fc Receptors in Disorders of the Central Nervous SystemNeuroMolecular Medicine, 2009
- Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase MacropinocytosisThe Journal of Neuroscience, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomersNeurobiology of Aging, 2008